You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,206,895


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,206,895 protect, and when does it expire?

Patent 10,206,895 protects SOTYLIZE and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 10,206,895
Title:Sotalol compositions and uses of the same
Abstract: The present invention provides oral solutions containing sotalol hydrochloride which advantageously avoid swallowing while providing with improved stability. The present invention also relates to methods of using the oral solutions for treatment of diseases and disorders, such as delay in reoccurrence of atrial fibrillation/atrial flutter and/or ventricular arrhythmias.
Inventor(s): Thomas; H. Greg (Carrollton, GA), Kiel; Jeffrey S. (Gainesville, GA)
Assignee: ARBOR PHARMACEUTICALS, INC. (Atlanta, GA)
Application Number:15/635,499
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,206,895

Introduction

United States Patent 10,206,895, titled "Sotalol compositions and uses of the same," is a patent that revolves around the development and application of oral solutions containing sotalol hydrochloride. This analysis will delve into the key aspects of the patent, including its scope, claims, and the broader patent landscape.

Patent Overview

The patent, assigned the number US10,206,895B2, was granted on February 19, 2019. It pertains to pharmaceutical compositions, specifically oral solutions of sotalol hydrochloride, which are designed to improve stability and avoid the need for swallowing whole tablets or capsules[4].

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific inventions and innovations covered. Here are the key elements:

Composition

The patent describes oral solutions containing sotalol hydrochloride, which are formulated to enhance stability and patient compliance. These solutions include various components such as buffering agents, preservatives, and pharmaceutical excipients to maintain the integrity of the sotalol hydrochloride[4].

Uses

The patent specifies the uses of these compositions, primarily focusing on the treatment of conditions that require the administration of sotalol hydrochloride. This includes the management of arrhythmias and other cardiovascular diseases[4].

Claims Analysis

The claims section of the patent is crucial as it defines the legal boundaries of the invention.

Independent Claims

Independent claims are those that stand alone and do not depend on other claims. For US10,206,895B2, these claims typically describe the composition of the oral solution, including the presence of sotalol hydrochloride and other necessary components.

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or limitations. These might include specific concentrations of sotalol hydrochloride, the presence of particular excipients, or the method of preparation[4].

Prior Art and Citation Analysis

The patent landscape surrounding US10,206,895B2 involves an analysis of prior art and citations.

Prior Art

Prior art refers to existing knowledge and inventions in the field that predate the current patent. The Common Citation Document (CCD) application, provided by the USPTO, can help consolidate citation data from multiple patent offices, ensuring that the invention is novel and non-obvious over existing prior art[1].

Citation Data

Citation data indicates how the patent is connected to other patents and publications. For US10,206,895B2, the citation data would show references to other patents and scientific literature related to sotalol hydrochloride formulations and their applications[4].

Inventorship and Ownership

Determining the correct inventors is crucial for the validity of a patent. US patent law requires that only the true and only inventors be listed on the patent application. Incorrect or deceptive inventorship can lead to the patent being declared invalid[2].

Patent Search and Documentation

To understand the broader patent landscape, one must conduct thorough patent searches. Tools like the USPTO's Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are invaluable for this purpose. These resources provide access to prior art, patent family information, and other relevant data[1].

Economic and Legal Implications

The economic implications of a patent like US10,206,895B2 can be significant. Patents can provide a competitive edge by protecting intellectual property and allowing the patent holder to exclude others from making, using, or selling the invention. The Patent Claims Research Dataset by the USPTO can provide insights into the economic impact of patent claims and the scope of patents over time[3].

Potential for Litigation and Enforcement

Given the importance of correct inventorship and the potential for disputes, patents like US10,206,895B2 may face litigation. The establishment of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could provide a more accessible and cost-effective way to resolve patent disputes[5].

Key Takeaways

  • Composition and Uses: The patent covers oral solutions of sotalol hydrochloride, enhancing stability and patient compliance.
  • Claims Analysis: Independent and dependent claims define the scope of the invention, including specific components and their concentrations.
  • Prior Art and Citation: Ensuring novelty and non-obviousness over prior art is crucial, facilitated by tools like the CCD application.
  • Inventorship: Correct determination of inventors is vital for the patent's validity.
  • Patent Search and Documentation: Thorough searches using USPTO resources are essential for understanding the patent landscape.
  • Economic and Legal Implications: Patents provide a competitive edge and can have significant economic implications, with potential for litigation and enforcement.

FAQs

Q1: What is the main subject matter of US Patent 10,206,895? The main subject matter is the development of oral solutions containing sotalol hydrochloride, designed to improve stability and patient compliance.

Q2: Why is correct inventorship important in patent applications? Correct inventorship is crucial because incorrect or deceptive inventorship can lead to the patent being declared invalid and unenforceable.

Q3: What tools can be used to conduct a thorough patent search related to US10,206,895B2? Tools such as the USPTO's Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are useful for conducting thorough patent searches.

Q4: How does the Common Citation Document (CCD) application help in patent searches? The CCD application consolidates citation data from multiple patent offices, helping to ensure that the invention is novel and non-obvious over existing prior art.

Q5: What are the potential economic implications of a patent like US10,206,895B2? The patent can provide a competitive edge by protecting intellectual property, allowing the patent holder to exclude others from making, using, or selling the invention, which can have significant economic implications.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Determining Inventorship for US Patent Applications: https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. US10206895B2 - Sotalol compositions and uses of the same - Google Patents: https://patents.google.com/patent/US10206895B2/en
  5. U.S. Patent Small Claims Court - ACUS: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,206,895

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity SOTYLIZE sotalol hydrochloride SOLUTION;ORAL 205108-001 Oct 22, 2014 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y SOTYLIZE IS INDICATED FOR THE MAINTENANCE OF NORMAL SINUS RHYTHM [DELAY IN TIME TO RECURRENCE OF ATRIAL FIBRILLATION/ATRIAL FLUTTER (AFIB/AFL)] IN PATIENTS WITH SYMPTOMATIC AFIB/AFL WHO ARE CURRENTLY IN SINUS RHYTHM ⤷  Subscribe
Azurity SOTYLIZE sotalol hydrochloride SOLUTION;ORAL 205108-001 Oct 22, 2014 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y INDICATED FOR THE TREATMENT OF VENTRICULAR ARRHYTHMIAS, SUCH AS SUSTAINED VENTRICULAR TACHYCARDIA, THAT IN THE JUDGEMENT OF THE PHYSICIAN ARE LIFE-THREATENING ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,206,895

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2015153762 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.